Inventor · disambiguated record
Masami Suzuki
Also filed as: SUZUKI MASAMI
13 granted patents·9 pending applications·27 citations·filing 2000–2022
87Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD11PHARMALOGICALS RES PTE LTD2TAKEDA PHARMACEUTICAL2YAMAZAKI TATSUMI2ABURATANI HIROYUKI1
Top patents by PatentIndex Score
22 records- 0180US8663929B2Method for detection of liver cancer cell using anti-glypican-3 antibodyKATAOKA HIROAKI·Filed 2009·Granted Mar 4, 2014·9 cites·12 claims
- 0279US9556264B2Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Jan 31, 2017·5 cites·25 claims
- 0376US8008076B2Method of producing a nucleic acid encoding an antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Aug 30, 2011·3 cites·17 claims
- 0474US6677363B1Agent for improving ketosisTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Jan 13, 2004·6 cites·16 claims
- 0572US7932289B2Remedy for diabetesTAKEDA PHARMACEUTICAL·Filed 2005·Granted Apr 26, 2011·3 cites·5 claims
- 0672US2023085803A1Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted thereinCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0769US11858987B2Cancer stem cell-specific moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 2, 2024·0 cites·17 claims
- 0867US8343761B2Methods of generating and using antibody-producing cellsCHUGAI PHARMACEUTICAL CO LTD·Filed 2011·Granted Jan 1, 2013·1 cites·35 claims
- 0962US11965180B2Cancer stem cell population and method for production thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Apr 23, 2024·0 cites·4 claims
- 1059US10934351B2Cancer stem cell-specific moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·22 claims
- 1159US2010267571A1Novel method for specimen preparation, which ensures preservation of tissue morphology and nucleic acid qualityCHUGAI PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 1256US7595333B2Agent for improving acidosisTAKEDA PHARMACEUTICAL·Filed 2003·Granted Sep 29, 2009·0 cites·6 claims
- 1353US2014302511A1Cancer stem cell-specific moleculePHARMALOGICALS RES PTE LTD·Filed 2012·Application pending·0 cites
- 1452US2006235207A1Antibodies against lesion tissuePHARMALOGICALS RES PTE LTD·Filed 2003·Application pending·0 cites
- 1551US10018630B2Cancer stem cell isolationYAMAZAKI TATSUMI·Filed 2012·Granted Jul 10, 2018·0 cites·8 claims
- 1651US2021293769A1Method for culturing cancer tissue or tissue analogous to cancer tissueCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1750US11536713B2Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted thereinSUZUKI MASAMI·Filed 2010·Granted Dec 27, 2022·0 cites·6 claims
- 1843US2008008710A1Therapeutic Agent And Diagnostic Agent For CholangiocarcinomaABURATANI HIROYUKI·Filed 2004·Application pending·0 cites
- 1943US2017129950A1Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active IngredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 2041US11124773B2Cancer stem cell population and method for production thereofYAMAZAKI TATSUMI·Filed 2011·Granted Sep 21, 2021·0 cites·5 claims
- 2141US2016159919A1Therapeutic Agent Comprising Humanized Anti-Epiregulin Antibody as Active Ingredient for Non-Small-Cell Lung Carcinoma Excluding AdenocarcinomaCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 2234US2003049211A1Remedies and preventives for dental diseasesFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masami Suzuki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →